Suhrbier A - Search Results

1

Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

Moyle PM, Olive C, Ho MF, Pandey M, Dyer J, Suhrbier A, Fujita Y, Toth I. Moyle PM, et al. Among authors: suhrbier a. J Med Chem. 2007 Sep 20;50(19):4721-7. doi: 10.1021/jm070287b. Epub 2007 Aug 17. J Med Chem. 2007. PMID: 17705361

2

Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein.

Darnell GA, Schroder WA, Antalis TM, Lambley E, Major L, Gardner J, Birrell G, Cid-Arregui A, Suhrbier A. Darnell GA, et al. Among authors: suhrbier a. J Biol Chem. 2007 Dec 28;282(52):37492-500. doi: 10.1074/jbc.M706860200. Epub 2007 Oct 31. J Biol Chem. 2007. PMID: 17977825 Free article.

3

Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.

Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfmann P, Kawaoka Y, Rehm BHA. Chen S, et al. Among authors: suhrbier a. Adv Healthc Mater. 2022 Feb;11(3):e2102089. doi: 10.1002/adhm.202102089. Epub 2021 Nov 10. Adv Healthc Mater. 2022. PMID: 34716678 Free PMC article.

4

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

Thomson SA, Elliott SL, Sherritt MA, Sproat KW, Coupar BE, Scalzo AA, Forbes CA, Ladhams AM, Mo XY, Tripp RA, Doherty PC, Moss DJ, Suhrbier A. Thomson SA, et al. Among authors: suhrbier a. J Immunol. 1996 Jul 15;157(2):822-6. J Immunol. 1996. PMID: 8752934

5

Multi-epitope DNA vaccines.

Suhrbier A. Suhrbier A. Immunol Cell Biol. 1997 Aug;75(4):402-8. doi: 10.1038/icb.1997.63. Immunol Cell Biol. 1997. PMID: 9315485 Review.

6

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.

Sherritt MA, Gardner J, Elliott SL, Schmidt C, Purdie D, Deliyannis G, Heath WR, Suhrbier A. Sherritt MA, et al. Among authors: suhrbier a. Eur J Immunol. 2000 Feb;30(2):671-7. doi: 10.1002/1521-4141(200002)30:2<671::AID-IMMU671>3.0.CO;2-H. Eur J Immunol. 2000. PMID: 10671225 Free article.

7

ISCOM based vaccines for cancer immunotherapy.

Lenarczyk A, Le TT, Drane D, Malliaros J, Pearse M, Hamilton R, Cox J, Luft T, Gardner J, Suhrbier A. Lenarczyk A, et al. Among authors: suhrbier a. Vaccine. 2004 Feb 25;22(8):963-74. doi: 10.1016/j.vaccine.2003.09.014. Vaccine. 2004. PMID: 15161073

8

Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production.

Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB, Flores Fde M, Vanags D, Naylor DJ, Hill GR, Suhrbier A. Johnson BJ, et al. Among authors: suhrbier a. J Biol Chem. 2005 Feb 11;280(6):4037-47. doi: 10.1074/jbc.M411569200. Epub 2004 Nov 16. J Biol Chem. 2005. PMID: 15546885 Free article.

9

Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

Darnell GA, Antalis TM, Rose BR, Suhrbier A. Darnell GA, et al. Among authors: suhrbier a. J Virol. 2005 Apr;79(7):4246-56. doi: 10.1128/JVI.79.7.4246-4256.2005. J Virol. 2005. PMID: 15767426 Free PMC article.

10

SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication.

Darnell GA, Schroder WA, Gardner J, Harrich D, Yu H, Medcalf RL, Warrilow D, Antalis TM, Sonza S, Suhrbier A. Darnell GA, et al. Among authors: suhrbier a. J Biol Chem. 2006 Oct 20;281(42):31348-58. doi: 10.1074/jbc.M604220200. Epub 2006 Aug 21. J Biol Chem. 2006. PMID: 16923810 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters